Docetaxel/gemcitabine vs. cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: Results of a randomised phase II trial

被引：0
|
作者：
Binder, D
Schweisfurth, H
Grah, C
Schäper, C
Temmesfeld-Wollbrück, B
Siebert, G
Suttorp, N
Beinert, T
机构：
[1] Univ Med Berlin, Med Klin MS Infektiol & Asthmapoliklin, Charite, Berlin, Germany
[2] Carl Thiem Klinikum, Med Klin 3, Cottbus, Germany
[3] Gemeinschaftskrankenhaus Havelhohe, Berlin, Germany
[4] Univ Med Berlin, Inst Med Biometrie, Charite, Berlin, Germany
[5] Klin Wartenberg, Wartenberg, Germany
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S237 / S237
页数：1
相关论文
共 50 条
  • [1] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial
    D. Binder
    H. Schweisfurth
    C. Grah
    C. Schäper
    B. Temmesfeld-Wollbrück
    G. Siebert
    N. Suttorp
    T. Beinert
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 143 - 150
  • [2] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: results of a multicentre randomized phase II trial
    Binder, D.
    Schweisfurth, H.
    Grah, C.
    Schaeper, C.
    Temmesfeld-Wollbrueck, B.
    Siebert, G.
    Suttorp, N.
    Beinert, T.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 143 - 150
  • [3] Docetaxel/gemcitabine vs. a sequential protocol comprising cisplatin/gemcitabine/docetaxel in the first-line treatment of patients with stage IV non-small cell lung cancer (NSCLC):: results of a randomised phase II trial
    Binder, D.
    Schweisfurth, H.
    Grah, C.
    Schaper, C.
    Temmesfeld-Wollbruck, B.
    Siebert, G.
    Suttorp, N.
    Beinert, T.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 326 - 326
  • [4] Sequential cisplatin-gemcitabine-docetaxel vs docetaxel-gemcitabine in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: Interim results of an ongoing phase II trial.
    Binder, D
    Beinert, T
    Schweisfurth, H
    Grah, C
    Temmesfeld-Wollbrock, B
    Müller-Hagen, G
    Schäper, C
    Schürmann, D
    Suttorp, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 644S - 644S
  • [5] Docetaxel-gemcitabine versus cisplatin-gemcitabine plus sequential docetaxel in the first-line treatment of metastatic non-small cell lung cancer (NSCLC): interim results of a randomized Phase II trial
    Binder, Daniel
    Beinert, Thomas
    Schweisfurth, Hans
    Grah, Christian
    Temmestfeld-Wollbrueck, Bettina
    Schaeper, Christoph
    Mueller-Hagen, Gerit
    Schuermann, Dirk
    Suttorp, Norbert
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 178 - 178
  • [6] Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer
    Novello, Silvia
    Falcone, Alfredo
    Crino, Lucio
    Rinaldi, Massimo
    Nardi, Mario
    De Marinis, Filippo
    Tonato, Maurizio
    Tibaldi, Carmelo
    Tinazzi, Angelo
    Russo, Francesca
    Grassivaro, Nicoletta
    Scagliotti, Giorgio Vittorio
    [J]. LUNG CANCER, 2009, 66 (03) : 327 - 332
  • [7] Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial
    Georgoulias, V
    Samonis, G
    Papadakis, E
    Alexopoulos, A
    Tsiafaki, X
    Rapti, A
    Veslemes, M
    Grigoratou, T
    Palamidas, P
    Kourossis, C
    Mavroudis, D
    Kakolyris, S
    Giannakakis, T
    Vlachonikolis, J
    [J]. LUNG CANCER, 2001, 34 : S47 - S51
  • [8] A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer
    Eleni M. Karapanagiotou
    Adrianni Charpidou
    Ifigenia Tzannou
    Kalliopi Dilana
    Elias Kotteas
    Ioannis Tourkantonis
    Epaminondas Kosmas
    Aspasia Provata
    Kostas Syrigos
    [J]. Medical Oncology, 2008, 25 : 303 - 308
  • [9] A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer
    Karapanagiotou, Eleni M.
    Charpidou, Adrianni
    Tzannou, Ifigenia
    Dilana, Kalliopi
    Kotteas, Elias
    Tourkantonis, Ioannis
    Kosmas, Epaminondas
    Provata, Aspasia
    Syrigos, Kostas
    [J]. MEDICAL ONCOLOGY, 2008, 25 (03) : 303 - 308
  • [10] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
12345